Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
omega-3 enriched SMOF lipid emulsion in mild to moderate traumatic brain injury
NCT02762539Unknown
- Sponsor
- Mansoura University
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Randomised, open-label trial of SMOFlipid in traumatic brain injury (TBI) (2 arms), sponsored by Mansoura University. Primary endpoint: Glasgow Coma Scale at 48 hours. Status: unknown.
02
Drugs
SMOFlipid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02762539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762539.